430 related articles for article (PubMed ID: 29224710)
1. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
[TBL] [Abstract][Full Text] [Related]
2. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
[TBL] [Abstract][Full Text] [Related]
4. SPM-1-producing Pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping.
Silva FM; Carmo MS; Silbert S; Gales AC
Microb Drug Resist; 2011 Jun; 17(2):215-20. PubMed ID: 21332364
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a hospital located in Rio de Janeiro, Brazil.
Carvalho AP; Albano RM; de Oliveira DN; Cidade DA; Teixeira LM; Marques Ede A
Microb Drug Resist; 2006; 12(2):103-8. PubMed ID: 16922625
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
[TBL] [Abstract][Full Text] [Related]
7. Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates.
Fehlberg LC; Xavier DE; Peraro PP; Marra AR; Edmond MB; Gales AC
Microb Drug Resist; 2012 Aug; 18(4):402-7. PubMed ID: 22455540
[TBL] [Abstract][Full Text] [Related]
8. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.
Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH
Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of carbapenem resistance in endemic Pseudomonas aeruginosa isolates after an SPM-1 metallo-β-lactamase producing strain subsided in an intensive care unit of a teaching hospital in Brazil.
Cacci LC; Chuster SG; Martins N; Carmo PR; Girão VB; Nouér SA; Freitas WV; Matos JA; Magalhães AC; Ferreira AL; Picão RC; Moreira BM
Mem Inst Oswaldo Cruz; 2016 Sep; 111(9):551-8. PubMed ID: 27653359
[TBL] [Abstract][Full Text] [Related]
11. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
Diene SM; L'homme T; Bellulo S; Stremler N; Dubus JC; Mely L; Leroy S; Degand N; Rolain JM
Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
[TBL] [Abstract][Full Text] [Related]
12. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
13. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Martins AF; Zavascki AP; Gaspareto PB; Barth AL
Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
15. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
[TBL] [Abstract][Full Text] [Related]
16. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
17. Changing the epidemiology of carbapenem-resistant Pseudomonas aeruginosa in a Brazilian teaching hospital: the replacement of São Paulo metallo-β-lactamase-producing isolates.
Cavalcanti FL; Almeida AC; Vilela MA; Morais MM; Morais Junior MA
Mem Inst Oswaldo Cruz; 2012 May; 107(3):420-3. PubMed ID: 22510840
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Gutiérrez O; Juan C; Cercenado E; Navarro F; Bouza E; Coll P; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2007 Dec; 51(12):4329-35. PubMed ID: 17938181
[TBL] [Abstract][Full Text] [Related]
19. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
Gales AC; Menezes LC; Silbert S; Sader HS
J Antimicrob Chemother; 2003 Oct; 52(4):699-702. PubMed ID: 12951331
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
